Prophylactic Photodynamic Therapy to Organ Transplant Patients
Study Details
Study Description
Brief Summary
To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Organ transplant recipients.
-
Age 40 years or older.
Exclusion Criteria:
-
Patients younger than 40 years and older than 70 years.
-
Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
-
Previous photodynamic therapy to the skin areas investigated.
-
Pregnancy or breast feeding patients.
-
Patients with porphyria.
-
Patients with a tendency to produce hypertrophic scars or keloids.
-
Patients with known allergy to Metvix.
-
Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Bispebjerg Hospital | Copenhagen | Copenhagen NV | Denmark | 2400 |
Sponsors and Collaborators
- Bispebjerg Hospital
Investigators
- Principal Investigator: Merete Hædersdal, MD, PhD, DrMedSci, Bispebjerg Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KF-01-314759